Sildenafil Tablet, Film Coated
Product Images NDC 71335-1005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-1005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351005)

Label Image (Lbl713351005)
This is a labeled package of Revatio, a type of Sildenafil Citrate tablet used for the treatment of pulmonary arterial hypertension. It contains 20mg of sildenafil citrate and should be stored at room temperature (20°-25°C or 68°-77°F). The package is labeled with a National Drug Code (NDC) number of 7133510051 050291125683.*
FDA Label Image

Figure-10 (Sildenafil Fig 10)

FDA Label Image

Figure-11 (Sildenafil Fig 11)

FDA Label Image

Fig-12 (Sildenafil Fig 12)

FDA Label Image

Fig-6 (Sildenafil Fig 6)

FDA Label Image

Fig-8 (Sildenafil Fig 8)

Fig-8 (Sildenafil Fig 8)
This text is a table that appears to contain information about the recommended fold change and 90% CI for various drugs and their interactions with other drugs. Some drugs require a dose adjustment while others do not. The table also shows relative change values for interacting drugs at different doses and mentions a clinical study regarding the addition of sildenafil to bosentan therapy.*
FDA Label Image

Figure-9 (Sildenafil Fig 9)

FDA Label Image

Figure-7 (Sildenafil Figure 7)

Figure-7 (Sildenafil Figure 7)
This is a table of recommended drug interactions for various drugs including Atorvastatin, Astromycin UG, Bosentan, Cimetidine, Everolimus, Bevacizumab, Oral Contraceptives, and Saquinavir. The table indicates which drugs require a dose adjustment and which do not. The last line mentions that adding sildenafil to bosentan therapy does not provide any benefits to exercise capacity.*
FDA Label Image

Str (Sildenafil Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.